About Anixa Biosciences, Inc.
https://www.anixa.comAnixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
CEO
Amit Kumar
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-06-26 | Reverse | 1:25 |
| 1996-06-18 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:1.42M
Value:$4.73M
D.A. DAVIDSON & CO.
Shares:614.27K
Value:$2.04M
LAIRD NORTON TRUST COMPANY, LLC
Shares:597.24K
Value:$1.99M
Summary
Showing Top 3 of 74
About Anixa Biosciences, Inc.
https://www.anixa.comAnixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $2.44M ▼ | $0 ▲ | 0% | $-0.07 ▲ | $-2.44M ▲ |
| Q2-2025 | $0 | $3M ▼ | $-2.79M ▲ | 0% | $-0.09 ▲ | $-2.99M ▲ |
| Q1-2025 | $0 | $3.39M ▲ | $-3.18M ▼ | 0% | $-0.1 ▼ | $-3.39M ▼ |
| Q4-2024 | $0 | $3.16M ▼ | $-2.88M ▲ | 0% | $0.3 ▲ | $-3.15M ▲ |
| Q3-2024 | $0 | $3.59M | $-3.28M | 0% | $-0.1 | $-3.59M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $16.03M ▲ | $17.65M ▲ | $2.24M ▲ | $16.59M ▲ |
| Q2-2025 | $15.6M ▼ | $16.98M ▼ | $2.07M ▼ | $16.07M ▼ |
| Q1-2025 | $17.25M ▼ | $18.91M ▼ | $2.19M ▼ | $17.85M ▼ |
| Q4-2024 | $19.92M ▼ | $21.59M ▼ | $2.7M ▲ | $20M ▼ |
| Q3-2024 | $20.75M | $22.91M | $2.22M | $21.77M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.28M ▲ | $-1.51M ▼ | $-833K ▼ | $1.93M ▲ | $-415K ▼ | $-1.51M ▼ |
| Q2-2025 | $-2.81M ▲ | $-1.5M ▲ | $2.34M ▼ | $18K ▲ | $857K ▲ | $-1.5M ▲ |
| Q1-2025 | $-3.21M ▼ | $-2.9M ▼ | $2.7M ▲ | $-17K ▼ | $-218K ▼ | $-2.9M ▼ |
| Q4-2024 | $-2.91M ▲ | $-927K ▲ | $867K ▼ | $106K ▼ | $46K ▼ | $-927K ▲ |
| Q3-2024 | $-3.28M | $-2.64M | $2.72M | $149K | $230K | $-2.64M |
CEO
Amit Kumar
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-06-26 | Reverse | 1:25 |
| 1996-06-18 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:1.42M
Value:$4.73M
D.A. DAVIDSON & CO.
Shares:614.27K
Value:$2.04M
LAIRD NORTON TRUST COMPANY, LLC
Shares:597.24K
Value:$1.99M
Summary
Showing Top 3 of 74